Medtronic SMall Annuli Randomized To Evolut or Sapien Trial (SMART Trial)

Age
18 years - 99 years
Gender
All
participants needed
400
Location
1
Find a site
Medtronic SMall Annuli Randomized To Evolut or Sapien Trial (SMART Trial)

Brief description of study

The purpose of this study is to collect information and compare the safety and performance of self-expanding (SE) versus balloon-expandable (BE) transcatheter aortic valve replacement (TAVR) in patients with a small aortic valve.

Study participants will be randomized on a 1:1 basis to receive transcatheter aortic valve replacement (TAVR) with either a Medtronic SE or an Edwards BE TAV. Randomization will be stratified by site and gender

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: pacemaker,heart disease,cadiac resynchronization
  • Age: 18 years - 99 years
  • Gender: All


Updated on 04 Aug 2024. Study ID: 848494

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Please provide your preferred way of contact
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center